These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18500649)

  • 1. Galanin and addiction.
    Picciotto MR
    Cell Mol Life Sci; 2008 Jun; 65(12):1872-9. PubMed ID: 18500649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galanin and addiction.
    Picciotto MR
    Exp Suppl; 2010; 102():195-208. PubMed ID: 21299070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galanin protects against behavioral and neurochemical correlates of opiate reward.
    Hawes JJ; Brunzell DH; Narasimhaiah R; Langel U; Wynick D; Picciotto MR
    Neuropsychopharmacology; 2008 Jul; 33(8):1864-73. PubMed ID: 17957220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal.
    Zachariou V; Brunzell DH; Hawes J; Stedman DR; Bartfai T; Steiner RA; Wynick D; Langel U; Picciotto MR
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):9028-33. PubMed ID: 12853567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galanin: a novel therapeutic target for depression, anxiety disorders and drug addiction?
    Holmes A; Picciotto MR
    CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):225-32. PubMed ID: 16611095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia.
    Basile AS; Fedorova I; Zapata A; Liu X; Shippenberg T; Duttaroy A; Yamada M; Wess J
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11452-7. PubMed ID: 12154229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galanin can attenuate opiate reinforcement and withdrawal.
    Picciotto MR; Hawes JJ; Brunzell DH; Zachariou V
    Neuropeptides; 2005 Jun; 39(3):313-5. PubMed ID: 15944028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-type specific expression and behavioral impact of galanin and GalR1 in the locus coeruleus during opioid withdrawal.
    Foster SL; Galaj E; Karne SL; Ferré S; Weinshenker D
    Addict Biol; 2021 Sep; 26(5):e13037. PubMed ID: 33768673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galanin-induced decreases in nucleus accumbens/striatum excitatory postsynaptic potentials and morphine conditioned place preference require both galanin receptor 1 and galanin receptor 2.
    Einstein EB; Asaka Y; Yeckel MF; Higley MJ; Picciotto MR
    Eur J Neurosci; 2013 May; 37(9):1541-9. PubMed ID: 23387435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors.
    Maldonado R; Saiardi A; Valverde O; Samad TA; Roques BP; Borrelli E
    Nature; 1997 Aug; 388(6642):586-9. PubMed ID: 9252189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of galanin binding sites and GalR1 mRNA levels in the mouse locus coeruleus following chronic morphine treatments and precipitated morphine withdrawal.
    Zachariou V; Thome J; Parikh K; Picciotto MR
    Neuropsychopharmacology; 2000 Aug; 23(2):127-37. PubMed ID: 10882839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent Adaptations in Afferents to Ventral Tegmental Dopamine Neurons after Opiate Withdrawal.
    Kaufling J; Aston-Jones G
    J Neurosci; 2015 Jul; 35(28):10290-303. PubMed ID: 26180204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of galanin on cocaine-mediated conditioned place preference and ERK signaling in mice.
    Narasimhaiah R; Kamens HM; Picciotto MR
    Psychopharmacology (Berl); 2009 May; 204(1):95-102. PubMed ID: 19099295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centrally administered galanin blocks morphine place preference in the mouse.
    Zachariou V; Parikh K; Picciotto MR
    Brain Res; 1999 Jun; 831(1-2):33-42. PubMed ID: 10411981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates.
    Drouin C; Darracq L; Trovero F; Blanc G; Glowinski J; Cotecchia S; Tassin JP
    J Neurosci; 2002 Apr; 22(7):2873-84. PubMed ID: 11923452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of galanin on monoaminergic systems and HPA axis: Potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors.
    Picciotto MR; Brabant C; Einstein EB; Kamens HM; Neugebauer NM
    Brain Res; 2010 Feb; 1314():206-18. PubMed ID: 19699187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addiction-related interactions of pregabalin with morphine in mice and humans: reinforcing and inhibiting effects.
    Vashchinkina E; Piippo O; Vekovischeva O; Krupitsky E; Ilyuk R; Neznanov N; Kazankov K; Zaplatkin I; Korpi ER
    Addict Biol; 2018 May; 23(3):945-958. PubMed ID: 28741741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction.
    Aston-Jones G; Smith RJ; Sartor GC; Moorman DE; Massi L; Tahsili-Fahadan P; Richardson KA
    Brain Res; 2010 Feb; 1314():74-90. PubMed ID: 19815001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice lacking the galanin gene show decreased sensitivity to nicotine conditioned place preference.
    Neugebauer NM; Henehan RM; Hales CA; Picciotto MR
    Pharmacol Biochem Behav; 2011 Mar; 98(1):87-93. PubMed ID: 21172385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats.
    Chartoff EH; Barhight MF; Mague SD; Sawyer AM; Carlezon WA
    Psychopharmacology (Berl); 2009 Jun; 204(2):227-39. PubMed ID: 19148621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.